
The Cigna Corp
Cigna Corporation (CI) is a large, US‑based health‑care and services company combining traditional health insurance with pharmacy and care‑management services through its Evernorth business. Its revenue mix includes employer and individual medical plans, Medicare products, and pharmacy benefit management and care solutions. Investors typically watch member trends, medical cost inflation, price negotiations with providers and drug‑pricing dynamics — all of which can move margins and earnings. Cigna’s business is sensitive to regulation, reimbursement changes and economic cycles that affect employer-sponsored coverage. With a market capitalisation of about $82.08 billion, it’s considered a major industry participant, but not immune to competition from insurers, PBMs and new entrants. This summary is general educational information, not personalised financial advice. Investors should consider their own circumstances, risk tolerance and seek regulated advice if needed; values can fall as well as rise and past performance is not a guide to future results.
Why It's Moving

Cigna rallies ahead of critical Q4 earnings, buoyed by veteran support pledge and upbeat analyst outlook.
- Renewed $1 million sponsorship over three years for Achilles Freedom Team, building on $3 million donated since 2009 to aid disabled athletes in major marathons.
- Q4 earnings webcast set for February 5, following Q3 2025's 10% revenue jump to $69.7 billion and reaffirmed full-year guidance of at least $29.60 per share.
- Analysts forecast 10.95% earnings growth to $33.03 per share, with consensus price target implying significant upside from recent levels around $279.

Cigna rallies ahead of critical Q4 earnings, buoyed by veteran support pledge and upbeat analyst outlook.
- Renewed $1 million sponsorship over three years for Achilles Freedom Team, building on $3 million donated since 2009 to aid disabled athletes in major marathons.
- Q4 earnings webcast set for February 5, following Q3 2025's 10% revenue jump to $69.7 billion and reaffirmed full-year guidance of at least $29.60 per share.
- Analysts forecast 10.95% earnings growth to $33.03 per share, with consensus price target implying significant upside from recent levels around $279.
When is the next earnings date for The Cigna Corp (CI)?
Cigna Group (CI) will release its fourth quarter 2025 financial results on February 5, 2026, before market open. The earnings report will cover the fiscal quarter ending December 31, 2025. The company will host a conference call on the same day to discuss the results. Analysts are forecasting full-year 2026 revenue of approximately $69.08 billion with EPS of $6.532, representing year-over-year growth of 5.17% and 27.33% respectively.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Cigna's stock, believing it could rise to $324.34 from $279.12.
Financial Health
Cigna is showing strong performance with good profits, cash flow, and solid revenue growth.
Dividend
Cigna's dividend yield of 2.12% offers a moderate return for income-focused investors. If you invested $1000 you would be paid $21.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CI
Healthcare's Cybersecurity Imperative
The massive cyberattack on UnitedHealth's subsidiary has exposed critical vulnerabilities within the national healthcare system. This event is accelerating the demand for advanced cybersecurity solutions, creating a significant growth opportunity for firms that specialize in protecting sensitive medical data and infrastructure.
Published: August 15, 2025
Explore BasketFollowing Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: August 15, 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: July 25, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketMedicaid Politics
Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.
Published: June 30, 2025
Explore BasketEmployee Mental Health As A Benefit
Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pharmacy & care growth
Evernorth’s pharmacy and care‑management services can drive revenue diversification and margin enhancement, though execution and pricing pressure matter.
US‑focused footprint
Cigna’s operations are primarily US‑centred, so domestic regulation and employer benefits trends heavily influence results; global shocks can still have indirect effects.
Regulation and margins
Policy shifts, reimbursement rates and drug pricing reforms can materially affect profitability — investors should factor regulatory risk into valuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Chemed Corp.
Provides hospice and palliative care services to patients facing life-limiting illness
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale Senior Living Inc.
A leading owner and operator of senior living communities in the United States.